Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and transferrin

daunorubicin has been researched along with transferrin in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's1 (11.11)29.6817
2010's5 (55.56)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Bradley, SJ; Gosriwitana, I; Hider, RC; Porter, JB; Srichairatanakool, S1
Elliott, RL; Head, JF; Wang, F1
Jin, J; Jones, AT; Pastrello, D; Penning, NA1
Du, J; Guo, J; Li, RJ; Lou, JN; Lu, WL; Men, Y; Shang, DW; Tian, W; Wen, H; Yang, TY; Ying, X; Zhang, LR; Zhang, Q; Zhang, Y1
Ju, RJ; Lu, WL; Tian, W; Wang, XX; Wen, H; Yao, HJ; Ying, X; Yu, Y; Zhang, L; Zhang, Y1
Bao, W; Chen, B; Li, X; Liu, R; Wang, F; Wang, Y; Xia, G; Yin, H; Zhang, H1
Bao, W; Chen, B; Chen, W; Cheng, J; Guo, L; Li, X; Liu, R; Wang, Y; Xia, G; Xu, Y1
Bao, W; Chen, B; Liu, R; Wang, F; Xia, G1
Chen, J; Zhang, W; Zhu, Y1

Other Studies

9 other study(ies) available for daunorubicin and transferrin

ArticleYear
Non-transferrin-bound iron induced by myeloablative chemotherapy.
    British journal of haematology, 1997, Volume: 99, Issue:2

    Topics: Adolescent; Adult; Blood Transfusion; Daunorubicin; Female; Hematopoiesis; Hodgkin Disease; Humans; Iron; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Transferrin; Transferrin; Transplantation Conditioning

1997
Antineoplastic drugs that interfere with iron metabolism in cancer cells.
    Advances in enzyme regulation, 1997, Volume: 37

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cisplatin; Clinical Trials as Topic; Daunorubicin; Deferoxamine; Female; Gallium; Humans; Indium; Iron; Rats; Transferrin; Tumor Cells, Cultured

1997
Clustering of endocytic organelles in parental and drug-resistant myeloid leukaemia cell lines lacking centrosomally organised microtubule arrays.
    The international journal of biochemistry & cell biology, 2008, Volume: 40, Issue:10

    Topics: Cell Line, Tumor; Centrosome; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Endocytosis; Endosomes; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Leukemia, Myeloid; Lysosomes; Microtubules; Models, Biological; Organelles; Protein Transport; Subcellular Fractions; Transferrin

2008
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
    Journal of controlled release : official journal of the Controlled Release Society, 2010, Jan-25, Volume: 141, Issue:2

    Topics: Aniline Compounds; Animals; Antibiotics, Antineoplastic; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Chemistry, Pharmaceutical; Daunorubicin; Drug Carriers; Flow Cytometry; Glioma; Liposomes; Male; Mannosides; Mice; Microscopy, Confocal; Rats; Rats, Sprague-Dawley; Spheroids, Cellular; Time Factors; Transferrin

2010
Pharmacokinetics and tissue distribution of dual-targeting daunorubicin liposomes in mice.
    Pharmacology, 2011, Volume: 87, Issue:1-2

    Topics: Aniline Compounds; Animals; Antibiotics, Antineoplastic; Blood-Brain Barrier; Brain; Brain Neoplasms; Chromatography, High Pressure Liquid; Daunorubicin; Drug Delivery Systems; Half-Life; Liposomes; Male; Mannosides; Metabolic Clearance Rate; Mice; Myocardium; Reproducibility of Results; Tissue Distribution; Transferrin

2011
PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Daunorubicin; Drug Delivery Systems; Humans; Mice; Nanoparticles; Polyesters; Polyethylene Glycols; Polylysine; Transferrin; Xenograft Model Antitumor Assays

2015
Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Antineoplastic Agents; Benzylisoquinolines; Cell Proliferation; Cell Survival; Daunorubicin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Hydrophobic and Hydrophilic Interactions; K562 Cells; Lactic Acid; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polylysine; Transferrin

2015
Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation.
    Drug design, development and therapy, 2019, Volume: 13

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Proliferation; Daunorubicin; Drug Screening Assays, Antitumor; Hematologic Neoplasms; Humans; K562 Cells; Mice; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Polyesters; Polylysine; Transferrin; Tumor Cells, Cultured

2019
Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles.
    Drug design, development and therapy, 2023, Volume: 17

    Topics: Animals; Cell Line, Tumor; Daunorubicin; Drug Delivery Systems; Leukemia; Ligands; Luteolin; Mice; Nanoparticles; Oligonucleotides; Transferrin

2023